Global Investors Lp Viking's Net Worth
Global Investors Lp Viking's net worth is estimated to be at least $868,437,309.68 as of 02/23/2025. CoreStreet's estimation of Global Investors Lp Viking's net worth is based on their sale of stock and current holding of stock.
Global Investors Lp Viking is Major Shareholder at BridgeBio Pharma Inc. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,065,616 units of BBIO stock on 01/31/2025. Their biggest sale was on 06/22/2023 when they sold 13,000,000 units of Roivant Sciences Ltd stock for $128,700,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $225,185,814.62
Total value of insider sells:
- $643,251,495.06
Most recent insider trade:
- Jan. 31, 2025
Global Investors Lp Viking's Insider Trading History
| BridgeBio Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 31, 2025 | Major Shareholder | 3,065,616 | $34.90 | Sell | $106,989,998.40 |
July 18, 2023 | Major Shareholder | 1,500,000 | $35.00 | Sell | $52,500,000.00 |
June 27, 2019 | Major Shareholder | 4,705,900 | $17.00 | Buy | $80,000,300.00 |
| Api Group Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 17, 2024 | Major Shareholder | 1,951,782 | $38.15 | Sell | $74,460,483.30 |
| 4D Molecular Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 4, 2024 | Major Shareholder | 540,000 | $19.53 | Sell | $10,546,200.00 |
May 9, 2023 | Major Shareholder | 850,000 | $16.00 | Buy | $13,600,000.00 |
| RayzeBio Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 19, 2023 | Major Shareholder | 1,388,889 | $18.00 | Buy | $25,000,002.00 |
| Inhibrx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 28, 2023 | Major Shareholder | 511,627 | $19.35 | Buy | $9,899,982.45 |
Oct. 7, 2022 | Major Shareholder | 1,333,333 | $30.00 | Buy | $39,999,990.00 |
Aug. 26, 2020 | Major Shareholder | 180,219 | $18.92 | Buy | $3,409,743.48 |
Aug. 24, 2020 | Major Shareholder | 46,161 | $19.43 | Buy | $896,908.23 |
| Roivant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 22, 2023 | Major Shareholder | 13,000,000 | $9.90 | Sell | $128,700,000.00 |
| Frazier Lifesciences Acquisition Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 2, 2022 | Major Shareholder | 847,062 | $10.08 | Buy | $8,538,384.96 |
| Amylyx Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 8, 2022 | Major Shareholder | 700,000 | $29.37 | Sell | $20,559,000.00 |
| Procept Biorobotics Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 18, 2022 | Major Shareholder | 1,249,000 | $29.90 | Sell | $37,345,100.00 |
| Figs Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 2, 2021 | Major Shareholder | 157,587 | $47.28 | Sell | $7,450,713.36 |
| Adaptive Biotechnologies Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 14, 2020 | Major Shareholder | 1,000,000 | $55.65 | Sell | $55,650,000.00 |
Nov. 11, 2020 | Major Shareholder | 2,500,000 | $49.52 | Sell | $123,800,000.00 |
| Zentalis Pharmaceuticals Llc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 1, 2020 | Major Shareholder | 500,000 | $50.50 | Sell | $25,250,000.00 |
April 7, 2020 | Major Shareholder | 725,000 | $24.80 | Buy | $17,980,000.00 |
| Axon Enterprise Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 5, 2018 | Major Shareholder | 14,285,714 | $1.75 | Buy | $24,999,999.50 |
| Wayfair Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 20, 2014 | Major Shareholder | 35,200 | $22.73 | Buy | $800,096.00 |
Nov. 3, 2014 | Major Shareholder | 2,400 | $25.17 | Buy | $60,408.00 |